US Market Open December 22
US Market Open: US indices to hold steady
- US markets are expected to open broadly flat, following European indices that are largely holding steady at midday following the heavy sell-off yesterday.
- The approval of a new US stimulus package has provided some confidence to markets but concerns over a new strain of the coronavirus is proving a headwind.
- In commodity markets, Brent was holding steady above $50 as concerns over a new strain of the virus prevents oil prices moving higher.
US indices hold steady
The S&P 500 is called to open 0.1% higher at 3698.4 after ending yesterday at 3693.6.
The Dow Jones is set to open broadly flat at 30196.0 from 30199.0 at the end of play on Monday.
Start trading the opportunities with indices today.
US Senate approves $900 billion stimulus package
The US Senate approved a stimulus package worth nearly $900 billion late on Monday. The vast bill includes but is not limited to nearly $300 billion in small business relief, $166 billion in new cheques and $120 billion to help the unemployed. The bill, which was tied to a wider one providing funding for the federal government, easily passed in both houses of Congress and will now have to be signed by president Donald Trump.
The stimulus package provides clarity for the economy as we head into the new year and steadies the ship until president-elect Joe Biden takes office in January. However, lead Democrat and speaker of the House Nancy Pelosi has already warned that talks about the next round of relief should start sooner rather than later.
European indices broadly flat after heavy sell-off
In Europe, markets were holding largely steady at midday following the sell-off yesterday that was driven by fears over the new strain of coronavirus.
The Euro STOXX Index traded largely flat at 3480.5 from 3481.6 at the end of yesterday’s session.
France’s CAC 40 was down 0.1% at 5439.0 from 5444.8, while Germany’s DAX was a smidgen higher at 13376.5 from 13369.8 at Monday’s close.
Meanwhile, over the Channel, the FTSE 100 was also slightly higher at midday at 6427.8 from 6423.8.
9 days until Brexit
Hopes of a Brexit deal were raised this morning as the UK and the EU edged closer to an agreement on fisheries but were plunged back into uncertainty after reports that the EU has rejected the UK’s latest offer to break the deadlock.
The UK and the EU were thought to be edging closer toward an agreement after the UK said it wanted to cut the value of fish the EU can catch in UK waters by one-third, compared to a 60% cut proposed last week. Meanwhile, the EU is thought to be standing firm and insisting on no more than a 25% reduction, but that has moved from the bloc’s initial threshold of 18%.
But reports from Bloomberg, citing two unnamed officials, said the EU has rejected that latest offer from the UK. The EU’s chief negotiator Michel Barnier is expected to brief ambassadors from member states at around 1500 GMT at a meeting in Brussels.
UK prime minister Boris Johnson warned yesterday that a no-deal Brexit would be ‘entirely satisfactory’ and the tight timeframe raises questions about whether any deal can be agreed and ratified in time to avoid a no-deal on December 31.
UK out in the cold thanks to new virus strain
In Europe, the focus continues to be the threat of a new strain of coronavirus that is thought to be considerably more transmissible than previous versions. The UK has seen over 40 countries ban UK arrivals and the border with France remains closed, causing carnage for the haulage industry.
European leaders are discussing a co-ordinated approach to the new variant of the virus, while France is looking at how the border could be reopened using new health protocols. It comes as the UK’s chief scientific advisor Patrick Vallance warned it is likely that more areas of the country will need to be put under tougher tier 4 restrictions after Christmas to try and keep on top of the new strain, which health secretary Matt Hancock has described as ‘out of control’.
Meanwhile, the EU is set to secure 12.5 million doses of the Pfizer-BioNTech vaccine before the end of the year after regulators gave it the green light yesterday. EU countries are expected to begin vaccinating their populations as early as Sunday.
CNN also reported Tuesday that Pfizer and Moderna were among those vaccine producers that were testing their vaccines on the new variant of the coronavirus found in the UK to ensure it can still provide immunity. Producers are confident existing vaccines will still prove effective, but it is expected to take weeks to provide any firm insight.
Forex: Pound gains on dollar but loses ground against euro
GBP/USD traded at 1.34190 at midday, down 0.3% from 1.34651 at the end of play on Monday.
EUR/USD was trading slightly lower at 1.22348 from 1.22437.
Meanwhile, Brexit uncertainty saw EUR/GBP move 0.3% higher at 0.91191 at midday from 0.90934 at the close yesterday.
Start trading the opportunities in the forex market today.
Commodities: Virus fears prevent oil pushing higher
Oil prices climbed to a nine-month high last week on hopes that the introduction of vaccines would allow countries to lift restrictions and get their economies back up and running. However, prices have struggled to move higher since then as fears grow that demand will remain subdued going into 2021 as the new virus strain forces countries to enforce tighter restrictions.
Brent traded at $50.61 at midday, holding steady from $50.87 at the close on Monday, while WTI was at $47.58 from $47.86.
Start trading the volatility in oil prices today.
Gold was also broadly flat at $1873 from $1878 at yesterday’s close.
Start trading gold and other precious metals today.
Market-moving events in the economic calendar
You can view all the scheduled events for today using our economic calendar, and keep up to date with the latest market news and analysis here.
This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.
StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.
In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.
StoneX Financial Pte. Ltd. is not under any obligation to update this report.
Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit www.cityindex.com/en-sg/terms-and-policies for the complete Risk Disclosure Statement.
ALL TRADING INVOLVES RISKS. LOSSES CAN EXCEED DEPOSITS.
City Index is a trading name of StoneX Financial Pte. Ltd. (“SFP”) for the offering of dealing services in Contracts for Differences (“CFD”). SFP holds a Capital Markets Services Licence issued by the Monetary Authority of Singapore for Dealing in Exchange-Traded Derivatives Contracts, Over-the-Counter Derivatives Contracts, and Spot Foreign Exchange Contracts for the Purposes of Leveraged Foreign Exchange Trading. SFP is also both Derivatives Trading and Clearing member of the Singapore Exchange (“SGX”). SFP is a wholly-owned subsidiary of StoneX Group Inc.
The information provided herein is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to invest, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk.
The information does not represent an offer of, or solicitation for, a transaction in any investment product. Any views and opinions expressed may be changed without an update. To understand the risks and costs involved, please visit the section captioned “Important Information” and the “Risk Disclosure Statement”.
The information herein is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation.
StoneX Financial Pte. Ltd. 1 Raffles Place, #18-61, One Raffles Place Tower 2, Singapore 048616. Tel: 6309 1000. Co. Reg. No.: 201130598R.
This advertisement has not been reviewed by the Monetary Authority of Singapore.
© City Index 2024